BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34468397)

  • 21. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.
    Weigel M; Riester A; Hanslik G; Lang K; Willenberg HS; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M
    Eur J Endocrinol; 2015 Apr; 172(4):443-50. PubMed ID: 25630564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
    Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
    Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism.
    Lin YH; Wang SM; Wu VC; Lee JK; Kuo CC; Yen RF; Liu KL; Huang KH; Chueh SC; Wang WJ; Lin LY; Chien KL; Ho YL; Chen MF; Wu KD;
    Eur J Clin Invest; 2011 Jul; 41(7):743-50. PubMed ID: 21250985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Relation Between the Degree of Left Ventricular Mass Regression and Serum Potassium Level Change in Patients With Primary Aldosteronism After Adrenalectomy.
    Liao CW; Chen A; Lin YT; Chang YY; Wang SM; Wu VC; Hung CS; Wu KD; Chueh SC; Lin YH;
    J Investig Med; 2015 Aug; 63(6):816-20. PubMed ID: 26083251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
    Tezuka Y; Turcu AF
    Front Endocrinol (Lausanne); 2021; 12():625457. PubMed ID: 33841329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.
    Grotevendt A; Wallaschofski H; Reincke M; Adolf C; Quinkler M; Nauck M; Hoffmann W; Rettig R; Hannemann A
    Endocrine; 2017 Aug; 57(2):298-307. PubMed ID: 28638984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxiety.
    Murck H; Adolf C; Schneider A; Schlageter L; Heinrich D; Ritzel K; Sturm L; Quinkler M; Beuschlein F; Reincke M; Künzel H
    J Psychiatr Res; 2021 May; 137():376-382. PubMed ID: 33761426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
    Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease.
    Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
    Cuspidi C; Tadic M; Sala C; Quarti-Trevano F; Gherbesi E; Mancia G; Grassi G
    J Hypertens; 2021 Apr; 39(4):775-783. PubMed ID: 33044383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
    Catena C; Colussi GL; Marzano L; Sechi LA
    Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using Renin Activity to Guide Mineralocorticoid Receptor Antagonist Therapy in Patients with Low Renin and Hypertension.
    Mansur A; Vaidya A; Turchin A
    Am J Hypertens; 2023 Jul; 36(8):455-461. PubMed ID: 37013957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment.
    Velema M; Dekkers T; Hermus A; Timmers H; Lenders J; Groenewoud H; Schultze Kool L; Langenhuijsen J; Prejbisz A; van der Wilt GJ; Deinum J;
    J Clin Endocrinol Metab; 2018 Jan; 103(1):16-24. PubMed ID: 29099925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.
    Chang YY; Liao CW; Tsai CH; Chen CW; Pan CT; Chen ZW; Chen YL; Lin LC; Chang YR; Wu VC; Wu KD; Hung CS; Lin YH; ;
    J Am Heart Assoc; 2019 Nov; 8(22):e013263. PubMed ID: 31718437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.
    Cesari M; Letizia C; Angeli P; Sciomer S; Rosi S; Rossi GP
    Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27307552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake.
    Adolf C; Heinrich DA; Holler F; Lechner B; Nirschl N; Sturm L; Görge V; Riester A; Williams TA; Treitl M; Ladurner R; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e484-93. PubMed ID: 31702016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of aldosterone on the development of left ventricular geometry and hypertrophy in patients with essential hypertension.
    Soylu A; Temizhan A; Duzenli MA; Sokmen G; Koylu O; Telli HH
    Jpn Heart J; 2004 Sep; 45(5):807-21. PubMed ID: 15557722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.